【24h】

Thrap 3 docks on phosphoserine 273 of PPAR γ and controls diabetic gene programming

机译:Thrap 3停靠在PPARγ的磷酸丝氨酸273上并控制糖尿病基因的编程

获取原文
获取原文并翻译 | 示例
           

摘要

Phosphorylation of peroxisome proliferator-activated receptor γ (PPARγ) at Ser273 by cyclin-dependent kinase 5 (CDK5) in adipose tissue stimulates insulin resistance, but the underlying molecular mechanisms are unclear. We show here that Thrap3 (thyroid hormone receptor-associated protein 3) can directly interact with PPARγ when it is phosphorylated at Ser273, and this interaction controls the diabetic gene programming mediated by the phosphorylation of PPARγ. Knockdown of Thrap3 restores most of the genes dysregulated by CDK5 action on PPARγ in cultured adipocytes. Importantly, reduced expression of Thrap3 in fat tissue by antisense oligonucleotides (ASOs) regulates a specific set of genes, including the key adipokines adiponectin and adipsin, and effectively improves hyperglycemia and insulin resistance in high-fat-fed mice without affecting body weight. These data indicate that Thrap3 plays a crucial role in controlling diabetic gene programming and may provide opportunities for the development of new therapeutics for obesity and type 2 diabetes.
机译:脂肪组织中细胞周期蛋白依赖性激酶5(CDK5)使Ser273处的过氧化物酶体增殖物激活受体γ(PPARγ)磷酸化,刺激了胰岛素抵抗,但潜在的分子机制尚不清楚。我们在这里显示Thrap3(甲状腺激素受体相关蛋白3)在Ser273磷酸化时可以直接与PPARγ相互作用,并且这种相互作用控制了由PPARγ磷酸化介导的糖尿病基因编程。敲除Thrap3可恢复CDK5对培养的脂肪细胞中PPARγ的作用而失调的大多数基因。重要的是,通过反义寡核苷酸(ASO)减少的Thrap3在脂肪组织中的表达调节了一组特定的基因,包括关键的脂联素脂联素和脂肪酶,并有效地改善了高脂饮食小鼠的高血糖症和胰岛素抵抗,而不会影响体重。这些数据表明Thrap3在控制糖尿病基因的编程中起着至关重要的作用,并可能为肥胖和2型糖尿病的新疗法的开发提供机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号